AT397939T

Stabilized liquid formulation, useful as a pharmaceutical composition or diagnostic reagent, comprises blood coagulation Factor VII activating protease and an aminoacid or derivative, e.g. ornithine or creatine, as stabilizer

Abstract

liquid preparation stabilized activating protease factor VII of blood coagulation or its proenzyme, characterized in that a) contains one or more compounds selected from ornithine group, diaminopimelic acid, agmatine, creatine, guanidinacético acid, acetylornithine, citrulline, argininosuccinic acid, tranexamic acid and epsilon-aminocaproic acid or its salts and derivatives b) exhibits a pH value between 2.0 and 8.0.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

14 members in 9 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
10100483GermanyA
10131404GermanyA

Members14

Family members, oldest first
DocumentOfficeKind
CA2366780A1CanadaA1
AU1006902AAustraliaA
DE10131404A1GermanyA1
KR20020060080ARepublic of KoreaA
EP1226829A2European Patent Office (EPO)A2
US2002110552A1United States of AmericaA1
JP2002249441AJapanA
EP1226829A3European Patent Office (EPO)A3
AU785103B2AustraliaB2
US7202065B2United States of AmericaB2
EP1226829B1European Patent Office (EPO)B1
AT397939TThis recordAustriaT
DE50114021D1GermanyD1
ES2307561T3SpainT3